Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06373861 · ClinicalTrials.gov registry record

Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)

A clinical trial of Sex Chromosome Aneuploidy, sponsored by University of Colorado, Denver.

Recruiting
Registry status
5,000
Enrollment target
1
Study location

NCT06373861 is a study of Sex Chromosome Aneuploidy that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 5,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06373861, a study of Sex Chromosome Aneuploidy, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
5,000 participants
Enrollment target
1
Study location

Study Summary

GALAXY is a registry research study that plans to learn more about individuals with X\&Y variations (also called sex chromosome aneuploidies) through collecting information from medical records.This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. The purpose of the GALAXY Registry is to collect and store this information with the overall goal to improve health outcomes in individuals with X\&Y variations and the care they receive.

Conditions Studied

Interventions

  • OTHER no intervention

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2022-04-28
Est. Completion 2037-04

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT06373861

The ClinicalTrials.gov registry entry for NCT06373861 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sex Chromosome Aneuploidy appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.

NCT06373861 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06373861 about?

NCT06373861 is a clinical study titled "Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)". GALAXY is a registry research study that plans to learn more about individuals with X\&Y variations (also called sex chromosome aneuploidies) through collecting information from medical records.This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of c...

What is the current status of trial NCT06373861?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-04-28. Estimated completion is 2037-04.

What conditions does trial NCT06373861 study?

This clinical trial studies the following conditions: Sex Chromosome Aneuploidy.

What interventions are being tested in trial NCT06373861?

The interventions under investigation include: no intervention (OTHER).

Who is sponsoring clinical trial NCT06373861?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06373861 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sex Chromosome Aneuploidy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.